FundedIQ
Biotechnology

iVeena: Funding, Investors & Team (Oct 2026)

iVeena has developed five products that are in the advanced stages of preclinical testing and research. These products are aimed at treating various eye conditions such as inflammation after cataract surgery, macular degeneration (Wet AMD), diabetic retinopathy, and glaucoma. The company, founded in 2006 by Bala Ambati, is located in Salt Lake City, Utah.

iveenamed.com LinkedIn Salt Lake City, United States 1-10 employees
Biotechnology Clinical Trials Life Science Medical Device B2B
Total raised
$3.0M
Rounds
1
Latest
Series B
Feb 2025

iVeena has raised $3.0M across 1 funding round on record, the most recent a Series B of $3.0M announced in Feb 2025.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

iVeena Company Profile and Key Stats

Total funding raised
$3.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$3.0M in Feb 2025
Employees
1-10
reported band
Headquarters
Salt Lake City, United States

Latest funding round on record: Feb 2025.

iVeena Funding Rounds

Date
Round
Amount
Series B
$3.0M

iVeena Founders and Leadership Team

Name
Role
Contact
Bala Ambati
Founder
—

No contact details are on record for this team yet.

iVeena Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
4,422
$32M

iVeena's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like iVeena in Biotechnology and Salt Lake City

Companies Similar to iVeena

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

iVeena Funding FAQs

What does iVeena do?

iVeena has developed five products that are in the advanced stages of preclinical testing and research. These products are aimed at treating various eye conditions such as inflammation after cataract surgery, macular degeneration (Wet AMD), diabetic retinopathy, and glaucoma. The company, founded in 2006 by Bala Ambati, is located in Salt Lake City, Utah.

How much funding has iVeena raised?

iVeena has raised $3.0M across 1 round on record. The most recent is a Series B of $3.0M announced in Feb 2025.

When did iVeena last raise funding?

iVeena's most recent funding round on record is a Series B of $3.0M, announced in Feb 2025.

Who founded iVeena?

FundedIQ lists Bala Ambati (Founder) at iVeena.

Where is iVeena headquartered?

iVeena is based in Salt Lake City, Utah, United States.

How many employees does iVeena have?

iVeena is in the 1-10 employee band.

How does iVeena's funding compare to other Biotechnology startups?

iVeena's latest round of $3.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's iVeena Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iVeena is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.